1-6 of 6
Authors: Faiza Ajana
Journal Article
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 9, September 2022, Pages 2506–2515, https://doi.org/10.1093/jac/dkac207
Published: 28 June 2022
Journal Article
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infection Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 3, March 2022, Pages 735–739, https://doi.org/10.1093/jac/dkab427
Published: 23 November 2021
Journal Article
Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 8, August 2021, Pages 2143–2147, https://doi.org/10.1093/jac/dkab149
Published: 29 May 2021
Journal Article
Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 6, June 2021, Pages 1564–1572, https://doi.org/10.1093/jac/dkab038
Published: 16 March 2021
Journal Article
Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine Get access
Journal of Antimicrobial Chemotherapy, Volume 53, Issue 1, January 2004, Pages 89–94, https://doi.org/10.1093/jac/dkh006
Published: 01 January 2004
Journal Article
Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment Get access
Journal of Antimicrobial Chemotherapy, Volume 51, Issue 6, June 2003, Pages 1377–1388, https://doi.org/10.1093/jac/dkg244
Published: 01 June 2003
